|
1
|
Song Y, Yuan Z, Ji J, Ruan Y, Li X, Wang L, Zeng W, Wu K, Hu W, Yi L, Ding H, Zhao M, Fan S, Li Z, Chen J. Development of a Ferritin-Based Nanoparticle Vaccine against Classical Swine Fever. Vaccines (Basel) 2024; 12:948. [PMID: 39204071 PMCID: PMC11360710 DOI: 10.3390/vaccines12080948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2024] [Revised: 08/14/2024] [Accepted: 08/20/2024] [Indexed: 09/03/2024] Open
Abstract
The occurrence of classical swine fever (CSF) poses a significant threat to the global swine industry. Developing an effective and safe vaccine is crucial for preventing and controlling CSF. Here, we constructed self-assembled ferritin nanoparticles fused with the classical swine fever virus (CSFV) E2 protein and a derived B cell epitope (Fe-E2B) using a baculovirus expression system (BVES), demonstrating enhanced immunogenicity. Furthermore, we provide a detailed evaluation of the immunological efficacy of the FeE2B in rabbits. The results showed that robust and sustained antibody responses were detected in rabbits immunized with the Fe-E2B nanoparticle vaccine, comparable to those elicited by commercially available vaccines. Additionally, we demonstrated that the vaccine effectively activated crucial immune factors IFN-γ and IL-4 in vivo, increasing their levels by 1.41-fold and 1.39-fold, respectively. Immunization with Fe-E2B enabled rabbits to avoid viremia and stereotypic fever after CSFV challenge. In conclusion, this study highlights the potential of ferritin nanoparticles as antigen-presenting carriers to induce robust immune responses, proposing a candidate vaccine strategy for the prevention and control of CSF.
Collapse
Affiliation(s)
- Yiwan Song
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Zhongmao Yuan
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Junzhi Ji
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Yang Ruan
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
| | - Xiaowen Li
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
| | - Lianxiang Wang
- Wen’s Group Academy, Wen’s Foodstuffs Group Co., Ltd., Xinxing 527400, China;
| | - Weijun Zeng
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Keke Wu
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Wenshuo Hu
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
| | - Lin Yi
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Hongxing Ding
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Mingqiu Zhao
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
| | - Shuangqi Fan
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| | - Zhaoyao Li
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Wen’s Group Academy, Wen’s Foodstuffs Group Co., Ltd., Xinxing 527400, China;
| | - Jinding Chen
- College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; (Y.S.); (Z.Y.); (J.J.); (Y.R.); (X.L.); (W.Z.); (K.W.); (W.H.); (L.Y.); (H.D.); (M.Z.); (S.F.)
- Key Laboratory of Zoonotic Disease Prevention and Control of Guangdong, South China Agricultural University, Guangzhou 510642, China
| |
Collapse
|
|
2
|
Yamashita M, Iwamoto S, Ochiai M, Yamamoto A, Sudo K, Narushima R, Nagasaka T, Saito A, Oba M, Omatsu T, Mizutani T, Yamamoto K. Pathogenicity of genotype 2.1 classical swine fever virus isolated from Japan in 2019 in pigs. Microbiol Immunol 2024; 68:267-280. [PMID: 38946035 DOI: 10.1111/1348-0421.13160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2023] [Revised: 05/13/2024] [Accepted: 06/09/2024] [Indexed: 07/02/2024]
Abstract
Classical swine fever (CSF) re-emerged in Japan in 2018 for the first time in 26 years. The disease has been known to be caused by a moderately pathogenic virus, rather than the highly pathogenic virus that had occurred in the past. However, the underlying pathophysiology remains unknown. This study conducted an experimental challenge on specific pathogen-free (SPF) pigs in a naïve state for 2, 4, and 6 weeks and confirmed the disease state during each period by clinical observation, virus detection, and pathological necropsy. We revealed the pathological changes and distribution of pathogens and virus-specific antibodies at each period after virus challenge. These results were comprehensively analyzed and approximately 70% of the pigs recovered, especially at 4- and 6-week post-virus challenge. This study provides useful information for future countermeasures against CSF by clarifying the pathogenicity outcomes in unvaccinated pigs with moderately pathogenic genotype 2.1 virus.
Collapse
Affiliation(s)
- Maiko Yamashita
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
- Center for Infectious Disease Epidemiology and Prevention Research, Tokyo University of Agriculture and Technology (Cooperative Division of Veterinary Sciences), Tokyo, Japan
| | - Shoko Iwamoto
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| | - Mariko Ochiai
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| | - Atsushi Yamamoto
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| | - Kasumi Sudo
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
- Livestock Industry Bureau, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| | - Rie Narushima
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| | - Takao Nagasaka
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| | - Akito Saito
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
- Exotic Diseases Research Station, National Institute of Animal Health, National Agriculture and Food Research Organization, Tokyo, Japan
| | - Mami Oba
- Center for Infectious Disease Epidemiology and Prevention Research, Tokyo University of Agriculture and Technology (Cooperative Division of Veterinary Sciences), Tokyo, Japan
| | - Tsutomu Omatsu
- Center for Infectious Disease Epidemiology and Prevention Research, Tokyo University of Agriculture and Technology (Cooperative Division of Veterinary Sciences), Tokyo, Japan
| | - Tetsuya Mizutani
- Center for Infectious Disease Epidemiology and Prevention Research, Tokyo University of Agriculture and Technology (Cooperative Division of Veterinary Sciences), Tokyo, Japan
| | - Kinya Yamamoto
- National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan
| |
Collapse
|
|
3
|
Huynh LT, Sohn EJ, Park Y, Kim J, Shimoda T, Hiono T, Isoda N, Hong SH, Lee HN, Sakoda Y. Development of a dual immunochromatographic test strip to detect E2 and E rns antibodies against classical swine fever. Front Microbiol 2024; 15:1383976. [PMID: 38666258 PMCID: PMC11043574 DOI: 10.3389/fmicb.2024.1383976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2024] [Accepted: 03/28/2024] [Indexed: 04/28/2024] Open
Abstract
Background It is essential to consider a practical antibody test to successfully implement marker vaccines and validate vaccination efficacy against classical swine fever virus (CSFV). The test should include a serological antibody assay, combined with a tool for differentiating infected from vaccinated animals (DIVA). The immunochromatographic test strip (ICS) has been exclusively designed for detecting CSFV E2 antibodies while lacking in detecting Erns antibodies, which can be employed and satisfy DIVA strategy. This study developed a novel ICS for detecting CSFV E2/Erns dual-antibody. The effectiveness of ICS in evaluating the DIVA capability of two novel chimeric pestivirus vaccine candidates was assessed. Methods Recombinant E2 or Erns protein was transiently expressed in the plant benthamiana using Agrobacterium tumefaciens. ICS was subsequently assembled, and goat anti-rabbit IgG and recombinant CSFV E2 or Erns protein were plated onto the nitrocellulose membrane as control and test lines, respectively. The sensitivity and specificity of ICS were evaluated using sera with different neutralizing antibody titers or positive for antibodies against CSFV and other pestiviruses. The coincidence rates for detecting E2 and Erns antibodies between ICS and commercial enzyme-linked immunosorbent assay (ELISA) kits were also computed. ICS performance for DIVA capability was evaluated using sera from pigs vaccinated with conventional vaccine or chimeric vaccine candidates. Results E2 and Erns proteins were successfully expressed in N. benthamiana-produced recombinant proteins. ICS demonstrated high sensitivity in identifying CSFV E2 and Erns antibodies, even at the low neutralizing antibody titers. No cross-reactivity with antibodies from other pestiviruses was confirmed using ICS. There were high agreement rates of 93.0 and 96.5% between ICS and two commercial ELISA kits for E2 antibody testing. ICS also achieved strong coincidence rates of 92.9 and 89.3% with two ELISA kits for Erns antibody detection. ICS confirmed the absence of CSFV Erns-specific antibodies in sera from pigs vaccinated with chimeric vaccine candidates. Conclusion E2 and Erns proteins derived from the plant showed great potential and can be used to engineer a CSFV E2/Erns dual-antibody ICS. The ICS was also highly sensitive and specific for detecting CSFV E2 and Erns antibodies. Significantly, ICS can fulfill the DIVA concept by incorporating chimeric vaccine candidates.
Collapse
Affiliation(s)
- Loc Tan Huynh
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
- Faculty of Veterinary Medicine, College of Agriculture, Can Tho University, Can Tho, Vietnam
| | - Eun-Ju Sohn
- BioApplications, Inc., Pohang, Gyeongsangbuk, Republic of Korea
| | - Youngmin Park
- BioApplications, Inc., Pohang, Gyeongsangbuk, Republic of Korea
| | - Juhun Kim
- BioApplications, Inc., Pohang, Gyeongsangbuk, Republic of Korea
| | | | - Takahiro Hiono
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
- One Health Research Center, Hokkaido University, Sapporo, Hokkaido, Japan
- International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan
- Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Hokkaido, Japan
| | - Norikazu Isoda
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
- One Health Research Center, Hokkaido University, Sapporo, Hokkaido, Japan
- International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan
- Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Hokkaido, Japan
| | - Sung-Hee Hong
- Celltrix Co., Ltd., Seongnam, Gyeonggi, Republic of Korea
| | - Ha-Na Lee
- Celltrix Co., Ltd., Seongnam, Gyeonggi, Republic of Korea
| | - Yoshihiro Sakoda
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
- One Health Research Center, Hokkaido University, Sapporo, Hokkaido, Japan
- International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan
- Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Hokkaido, Japan
| |
Collapse
|
|
4
|
Huynh LT, Isoda N, Hew LY, Ogino S, Mimura Y, Kobayashi M, Kim T, Nishi T, Fukai K, Hiono T, Sakoda Y. Generation and Efficacy of Two Chimeric Viruses Derived from GPE - Vaccine Strain as Classical Swine Fever Vaccine Candidates. Viruses 2023; 15:1587. [PMID: 37515273 PMCID: PMC10384557 DOI: 10.3390/v15071587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 07/17/2023] [Accepted: 07/19/2023] [Indexed: 07/30/2023] Open
Abstract
A previous study proved that vGPE- mainly maintains the properties of classical swine fever (CSF) virus, which is comparable to the GPE- vaccine seed and is a potentially valuable backbone for developing a CSF marker vaccine. Chimeric viruses were constructed based on an infectious cDNA clone derived from the live attenuated GPE- vaccine strain as novel CSF vaccine candidates that potentially meet the concept of differentiating infected from vaccinated animals (DIVA) by substituting the glycoprotein Erns of the GPE- vaccine strain with the corresponding region of non-CSF pestiviruses, either pronghorn antelope pestivirus (PAPeV) or Phocoena pestivirus (PhoPeV). High viral growth and genetic stability after serial passages of the chimeric viruses, namely vGPE-/PAPeV Erns and vGPE-/PhoPeV Erns, were confirmed in vitro. In vivo investigation revealed that two chimeric viruses had comparable immunogenicity and safety profiles to the vGPE- vaccine strain. Vaccination at a dose of 104.0 TCID50 with either vGPE-/PAPeV Erns or vGPE-/PhoPeV Erns conferred complete protection for pigs against the CSF virus challenge in the early stage of immunization. In conclusion, the characteristics of vGPE-/PAPeV Erns and vGPE-/PhoPeV Erns affirmed their properties, as the vGPE- vaccine strain, positioning them as ideal candidates for future development of a CSF marker vaccine.
Collapse
Affiliation(s)
- Loc Tan Huynh
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- Faculty of Veterinary Medicine, College of Agriculture, Can Tho University, Can Tho 900000, Vietnam
| | - Norikazu Isoda
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- One Health Research Center, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Hokkaido, Japan
- Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Hokkaido, Japan
| | - Lim Yik Hew
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
| | - Saho Ogino
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
| | - Yume Mimura
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
| | - Maya Kobayashi
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
| | - Taksoo Kim
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
| | - Tatsuya Nishi
- Kodaira Research Station, National Institute of Animal Health, National Agriculture and Food Research Organization, Kodaira 187-0022, Tokyo, Japan
| | - Katsuhiko Fukai
- Kodaira Research Station, National Institute of Animal Health, National Agriculture and Food Research Organization, Kodaira 187-0022, Tokyo, Japan
| | - Takahiro Hiono
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- One Health Research Center, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Hokkaido, Japan
| | - Yoshihiro Sakoda
- Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- One Health Research Center, Hokkaido University, Sapporo 060-0818, Hokkaido, Japan
- International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Hokkaido, Japan
- Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Hokkaido, Japan
| |
Collapse
|
|
5
|
Zhang Y, Na D, Zhang W, Liu X, Miao S, Tan WS, Zhao L. Development of stable HEK293T cell pools expressing CSFV E2 protein: A potential antigen expression platform. Vaccine 2023; 41:1573-1583. [PMID: 36725430 DOI: 10.1016/j.vaccine.2023.01.038] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 10/15/2022] [Accepted: 01/16/2023] [Indexed: 02/03/2023]
Abstract
Large quantities of antigens are required since protective antigens, such as classical swine fever virus (CSFV) E2 protein, are widely used in diagnostic reagents and subunit vaccines. Compared to clonal cell lines and transient gene expression, stable cell pools provide a potential alternative platform to rapidly produce large amounts of antigens. In this work, firstly, Human embryonic kidney 293 T (HEK293T) cell pools expressing E2 protein were developed by transduction of lentiviral vectors. On the one hand, the SP7 was selected from 7 well-performing signal peptides to remarkably increase the production of E2 protein. On the other hand, it was found that high MOI could improve the expression of E2 protein by increasing gene copy numbers. Moreover, the HEK293T cell pools were evaluated for stability by passages and batch cultures, demonstrating that the cell pools were stable for at least 90 days. And then, the performance of the cell pools in batch, fed-batch, and semi-perfusion was studied. Among them, the titer of E2 protein was up to 2 g/L in semi-perfusion, which is currently the highest to the authors' knowledge. Finally, the aggregations and immunogenicity of the E2 protein were analyzed by SDS-PAGE and immunization of mice, respectively. There was no significant difference in aggregations and antibody titers of E2 protein in three culture methods. These results suggest that stable HEK293T cell pools are a promising and robust platform for rapid and efficient production of recombinant proteins.
Collapse
Affiliation(s)
- Yanmin Zhang
- The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
| | - Daoyuan Na
- The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
| | - Weijian Zhang
- The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
| | - Xuping Liu
- Shanghai Bioengine Sci-Tech Co Ltd, Shanghai 201203, China
| | - Shiwei Miao
- Hangzhou Sumgen Biotech Co Ltd, Zhejiang 310056, China
| | - Wen-Song Tan
- The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
| | - Liang Zhao
- The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
| |
Collapse
|
|
6
|
Wang L, Mi S, Madera R, Li Y, Gong W, Tu C, Shi J. A Novel Competitive ELISA for Specifically Measuring and Differentiating Immune Responses to Classical Swine Fever C-Strain Vaccine in Pigs. Viruses 2022; 14:1544. [PMID: 35891524 PMCID: PMC9315997 DOI: 10.3390/v14071544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 07/07/2022] [Accepted: 07/13/2022] [Indexed: 11/17/2022] Open
Abstract
Classical swine fever can be controlled effectively by vaccination with C-strain vaccine. In this study, we developed a novel competitive enzyme-linked immunosorbent assay (cELISA) based on a C-strain Erns specific monoclonal antibody (mAb 1504), aiming to serologically measure immune responses to C-strain vaccine in pigs, and finally to make the C-strain become a DIVA-compatible vaccine. The cELISA system was established based on the strategy that mAb 1504 will compete with the C-strain induced antibodies in the pig serum to bind the C-strain Erns protein. The cELISA was optimized and was further evaluated by testing different categories of pig sera. It can efficiently differentiate C-strain immunized from wild-type CSFV-infected pigs and lacks cross-reaction with other common swine viruses and viruses in genus Pestivirus such as Bovine viral diarrhea virus (BVDV). The C-strain antibody can be tested in pigs 7-14 days post vaccination with this cELISA. The sensitivity and specificity of the established cELISA were 100% (95% confidence interval: 95.60 to 100%) and 100% (95% confidence interval: 98.30 to 100%), respectively. This novel cELISA is a reliable tool for specifically measuring and differentiating immune responses to C-strain vaccine in pigs. By combining with the wild-type CSFV-specific infection tests, it can make the C-strain have DIVA capability.
Collapse
Affiliation(s)
- Lihua Wang
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA; (R.M.); (Y.L.)
| | - Shijiang Mi
- Key Laboratory of Zoonoses Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130012, China; (S.M.); (W.G.); (C.T.)
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun 130012, China
| | - Rachel Madera
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA; (R.M.); (Y.L.)
| | - Yuzhen Li
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA; (R.M.); (Y.L.)
| | - Wenjie Gong
- Key Laboratory of Zoonoses Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130012, China; (S.M.); (W.G.); (C.T.)
| | - Changchun Tu
- Key Laboratory of Zoonoses Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130012, China; (S.M.); (W.G.); (C.T.)
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun 130012, China
| | - Jishu Shi
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA; (R.M.); (Y.L.)
| |
Collapse
|